MEDICALLY REVIEWED

Treatment of HER2+ Breast Cancer: Kanjinti, a biosimilar to trastuzumab

Trastuzumab Kanjinti

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

thailand baby free
Thailand Launches Free Newborn Screenings to Boost Birth Rates and Child Health

Thailand’s government noted a steady drop in the nation’s birth rate. Therefore, they took an assertive step to safeguard the health of the newest generation. The Department of Medical Sciences (DMS) and the National Health Security Office (NHSO) of Thailand have announced a new initiative that offers free screenings for newborns to detect 24 rare medical conditions. They designed this proactive move as part of a wider strategy to bolster the nation’s children’s health. Currently, the birth rate averages 1.4 births per woman, which contributes to an ageing population.

Read More »